Login / Signup
The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapy.
Xin Xu
Wei Zhao
Cuicui Liu
Yongsheng Gao
Dawei Chen
Meng Wu
Chao Li
Xinzhao Wang
Xiang Song
Jinming Yu
Zhaoyun Liu
Zhiyong Yu
Published in:
BMC cancer (2024)
These data suggest that RCB can be equally applied to predict RFS in Chinese patients with NAC. The application of RCB may help guide the selection of treatment strategies.
Keyphrases
</>
neoadjuvant chemotherapy
locally advanced
papillary thyroid
lymph node
sentinel lymph node
transcription factor
electronic health record
childhood cancer
big data
rectal cancer
squamous cell carcinoma
lymph node metastasis
risk factors
early stage
young adults
machine learning
deep learning